Clinical Trial Update: N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study) [Phase 2]

View source ↗

Summary

The INACT Phase 2 trial update reports completion and results posting for N-acetylcysteine in neonates undergoing congenital heart surgery, including procedures…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Transposition of the Great Arteries

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Michigan | Conditions: Transposition of Great Vessels, Congenital Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-01-19